Jessica Filderman, PhD

Why did you choose the University of Pittsburgh?

I chose Pitt because of the breadth of immunology research being done here and the collaborative environment. Pitt also offers the opportunity to work on translational research.

Education & Training

  • PhD in Microbiology and Immunology, University of Pittsburgh School of Medicine, 2024
  • BS in Biomedical Engineering, Washington University in St. Louis, 2013

Research Interests

Tumor immunology

Publications

Filderman, J. N., Appleman, M., Chelvanambi, M., Taylor, J. L., & Storkus, W. J. (2021). STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development. Frontiers in Immunology, 12, 1826. 

Filderman, J. N., & Storkus, W. J. (2020). Neoepitopes as Difference Makers for General Cancer Vaccines? Clinical Cancer Research, 26(17), 4429–4431. 

Avery, L., Filderman, J. N., Szymczak-Workman, A. L., & Kane, L. P. (2018). Tim-3 co-stimulation promotes short-lived effector T cells, restricts memory precursors, and is dispensable for T cell exhaustion. Proceedings of the National Academy of Sciences, 115(10), 2455–2460.